Ronald Mandel

Dr. Mandel is a Professor of Neurosciences at the University of Florida with over 25 years’ experience in the study of neurodegenerative diseases, with a particular focus on Parkinson’s disease. His laboratory is a leader in preclinical studies in the use of AAV for gene therapy. Prior to accepting the academic appointment in the Powell Gene Therapy Center, he developed gene therapy applications for the brain at Somatix Inc. and CellGenesys Inc.